Your search returned 2 results.

Results
	1.	Assessment of time to clinical response, a proxy for discharge readiness, among hospitalized patients with community-acquired pneumonia who received either ceftaroline fosamil or ceftriaxone in two phase III FOCUS trials. MedStar authors: Shorr, Andrew F PMID: 25487791 Year: 2015 Citation: Antimicrobial Agents & Chemotherapy. 59(2):1119-26, 2015 Feb. Institution: MedStar Washington Hospital Center Department: Medicine/Pulmonary-Critical Care Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Anzueto AR, File TM, Huang X, Lodise TP, Shorr AF, Smith A, Weber DJ, Yang M, Zhao Q DOI: http://dx.doi.org/10.1128/AAC.03643-14 Add to cart (remove)
	2.	Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials. MedStar authors: Shorr, Andrew F PMID: 23357290 Year: 2013 Citation: Diagnostic Microbiology & Infectious Disease. 75(3):298-303, 2013 Mar. Institution: MedStar Washington Hospital Center Department: Medicine/Pulmonary-Critical Care Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Eckburg PB, Friedland HD, Kollef M, Llorens L, Shorr AF DOI: http://dx.doi.org/10.1016/j.diagmicrobio.2012.12.002 Add to cart (remove)

Powered by Koha